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A large number of antibiotic peptides of fungal origin related to alamethicin have been 
extensively investigated for their structural and membrane rnodlfylng properties. 
Alamethicin and related peptides are characterised by a high content of a-aminoisobutyric 
acid (Aib) residues, posses a C-terminal alcohol residue, are blocked at the N-terminus 
and are produced in fungal cultures as complex microheterogenous mixtures (Mathew and 
Balaram, 1983). This family of peptide antibiotics termed peptaibols have proved useful in 
developing models for peptide channel formation (Sansom, 1993). The efrapeptins are a 
unique class of Aib containing peptides of fungal origin which contain a strongly basic C-  
terminus residue, in contrast to the members of the peptaibol family. 
Efrapeptins ( produced by the fungus Tolypocladium niveum)* a rnicroheterogenous 
mixture of fifteen residue long hydrophobic peptides(Bullough et al., 1982a), with the N- 
terminal acetylated and the C- terminal blocked by 1 -is0 butyl-2-[ 1 -pyrrolo-( 1,2-a) 
pyrimidinium-2,3,4,6,7,8-hexhydrolethyla (Gupta et al., 1992) are known to be 
inhibitors of ATP synthesis. They bind to F1-ATPase(Lardy et al., 1975). They inhibit ATP 
synthesis in intact mitochondnal FoF1-ATPase and ATP hydrolysis in isolated F1- 
ATPase(Cross and Kohlbrenner, 1978). 
The sequence of efrapeptin is: 
The replacement of the underhed residues Aib by Iva and Gly by Ala results in a 
microheterogenous mixture of efrapeptins designated efrapeptins C-G. 
X is the 
condensation product 
of Ieucinol and 
1,s-diaza- 
bicyclo[4:3:0]nonene 
* efrapeptins were first isolated by Drs. R . L . H d  and .J.G.Wfutney at the Ldly Research 
Laboratories, Indianapolis, as cited in Linnett,P.E. and Beechey, R.B. (1979) 
Meth. Enzyml, LV, 472-5 18. 
The purpose of the work presented in thls thesis was to isolate and puIlfy efra~eptins from 
fungal cultures with a view towards studymg their solution conformation and to examine 
the possibility of isolating precursor peptides which may provide a clue to the biosynthetic 
origin of the C-terminal 1,5-diazabicyclo[4:3:0]nonene group. Conformational studies 
were also undertaken on smaller peptides corresponding to the C-terminus of efrapeph. 
Chapter 1 gives a brief back ground to Aib containing membrane rnodlfylng peptides and 
available biochemical data on efrapeptins and their ability to inhibit FOR-ATPSe. The 
extensive information on the conformational properties of Aib residues in ~eptides is 
briefly discussed. 
Chapter 2 deals with the isolation, and purification of efrapeptin-D. Efrapeptins were 
isolated from Tolypocladium niveum (obtained from ATCC, USA.), punfied initially O n  a 
basic alumina column and subsequently on a reverse phase Cq column to obtain a 
microheterogenous mixture of efrapeptins C-G. This mixture was further ~ u d l e d  by 
, I-IPLC on a pKb- 100 basic column to obtain efrapeptin-D. 
Elvapeptins, another microheterogenous mixture of peptides produced by ~ o l ~ ~ o c l a d i u m  
niveum under the same culture conditions but at a stage earlier than the efrapeptins have 
the same peptide component as that of efrapeptins, but an additional mass of 20Da 
(Buffough et al., 1982b). The present study was based on the presumption that the C- 
terminal block is spermidine. Indeed, precedence for the formation of 15- 
diazabicyclo[4:3:0]nonene(DBN) from spermidine is known in two cases. In one case 
spennidine was oxidised to DBN by the bacteria Neisseria perflava (Weaver and Herbst, 
1958) and in the second case aerial oxidation of spermidine in pyndine using catalytic 
amounts of cuprous chloride yielded DBN(Croker et al., 1983). Elvapeptins could thus be 
the precursors of efrapeptins. Elvapeptins were isolated from cultures of ~ o l ~ ~ o c l a d i u m  
niveum on fermentation for five days. Their identity was estabhhed by electrospray mass 
spectrometry. Acetylation yielded triply acetylated elvapeptins consistent with spennidine 
being the C-terminal bloclung residue. 
Crude extracts of the fungal culture also contained fragments of efrapeptin(identi.fied by 
MALDI mass spectrometry) that were further acetylated and monoacetyl fragments 
obtained. The presence of the fragments in the broth indicate efrapeptins might be 
assembled in a segmental fashion. 
Chapter 3 describes the solution state conformation of efiapeptin-D in organic solvents. 
Circular dichroism studies support a helical structure and NMR experiments(TOCSY, 
ROESY and temperature dependence of NH chemical shlfls) indicate that helical 
fragments 1-5 and 10-15 are lmked by a flexible linker (residues 6-9) in efiapeptin-D. 
Specific aggregation of efrapeptin in aqueous medium to form vesicles has been observed 
by electron microscopy. The critical aggregation concentration and phase transition 
temperature were determined by fluorescence using ANS (1-anilino-%naphthalene 
sulfonic acid) as an extrinsic probe. 
Chapter 4 describes the synthesis of three peptides corresponding to the C-terminus of 
efrapeptin. Boc-LUL-OMe, Boc-GLUL-OMe and Boc-UGLUL-OMe (U=Aib) were 
synthesised by conventional solution phase procedures. The crystal structure of the 
tripeptide Boc-LUL-OMe revealed an unexpected non-P-turn structure, in contrast to the 
anticipated p-turn structure. In solution, NMR evidence favours a preponderance of P- 
turn conformations. A non- $- turn conformation was also obtained for the -LU- segment in 
the tetrapeptide Boc-GLUL-OMe in crystals. In solution, NMR studies (ROESY, solvent 
perturbation and radical induced broadening) support a p-turn conformation with a,4+1 
hydrogen bond for both the peptides. The peptide Boc-UGLUL-OMe is a p-turn in 
solution. CD studies in methanol, acetonitrile, trifluoroethanol and 
dicloromethane/c yclo hexane, provide evidence for conformational interchange between 
various types of 9-turns. 
Chapter 5 describes synthesis of peptides Boc-LLUL-OMe, Boc-LULL-OMe, Boc- 
GLULL-OMe, and Boc-LGLULL-OMe. These sequences were designed so as to 
investigate the conformation adopted by the -LU- fragment in leucine rich peptides. In 
crystals of Boc-LULL-OMe the -LU- segment adopts a type 111 /hum conformation, and 
a type II p-turn conformation in crystals of Boc-GLULL-OMe. In solution all the four 
peptides adopt p-turn structures at the -LU- segment (as established by NMR studies) CD 
studies again provide evidence for solvent dependence of backbone conformation. 
Chapter 6 describes the synthesis, NMR studies and x-ray diffraction studies on the C- 
terminal fragment analog of efrapeptin, Boc-PUGLUL-OMe. This crystal structure reveals 
a short helical segment terminating in a Schehan motif. NMR studies indicate a 310 
helical structure for Boc-PUGLUL-OMe. CD studies in methanol-trifluoroethanol 
mixtures indicate solvent dependent changes in the conformational composition of thls 
peptide. 
Chapter 7 summarises the overall contribution of this thesis towards the understanding of 
the solution state conformation of efrapeptin-D, solution and solid state conformations(in 
four cases) of the C-terminus peptides of efrapeptin and to some extent the biosynthesis of 
efrapeptins. 
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